SGLT1 is generally expressed in the normal epithelial cells of the small intestine to transport glucose and galactose across the luminal side of enterocytes, but its overexpression in prostate cancer [58] and colorectal cancer [59] is associated with poor prognosis. This evidence concerns the gene SLC5A1 and prostate carcinoma.